ES2005549A6 - Metodo para preparar una formulacion farmaceutica de liberacion controlada y accion prolongada y metodo de preparar una pluralidad de dosis de dicha formulacion. - Google Patents

Metodo para preparar una formulacion farmaceutica de liberacion controlada y accion prolongada y metodo de preparar una pluralidad de dosis de dicha formulacion.

Info

Publication number
ES2005549A6
ES2005549A6 ES8700956A ES8700956A ES2005549A6 ES 2005549 A6 ES2005549 A6 ES 2005549A6 ES 8700956 A ES8700956 A ES 8700956A ES 8700956 A ES8700956 A ES 8700956A ES 2005549 A6 ES2005549 A6 ES 2005549A6
Authority
ES
Spain
Prior art keywords
uniform
mixture
base material
therapeutic agent
longacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700956A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES2005549A6 publication Critical patent/ES2005549A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODO PARA PREPARAR UNA FORMULACION FARMACEUTICO DE LIBERACION CONTROLADA Y ACCION PROLONGADA Y METODO DE PREPARAR UNA MULTIPLICIDAD DE DOSIS DE DICHA FORMULACION, QUE COMPRENDE MEZCLAR HOMOGENEAMENTE UN MATERIAL VEHICULO CONSTITUIDO POR AL MENOS UN ETER CELULOSICO CON UN AGENTE TERAPEUTICO, DEJAR EN REPOSO LA MEZCLA FORMADA PARA PERMITIR QUE DICHO AGENTE TERAPEUTICO SE UNA CON DICHO ETER CELULOSICO, Y COMPRIMIR DICHA FORMULACION EN FORMA DE ROTULAS, TABLETAS O SUPOSITORIOS. EL INVENTO SE APLICA A MEDICAMENTOS EN LOS QUE ES NECESARIO LOGRAR NIVELES ESTABLES EN SANGRE DE DIVERSOS AGENTES TERAPEUTICOS.
ES8700956A 1986-04-04 1987-04-03 Metodo para preparar una formulacion farmaceutica de liberacion controlada y accion prolongada y metodo de preparar una pluralidad de dosis de dicha formulacion. Expired ES2005549A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/848,702 US4775535A (en) 1986-04-04 1986-04-04 Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics

Publications (1)

Publication Number Publication Date
ES2005549A6 true ES2005549A6 (es) 1989-03-16

Family

ID=25304046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700956A Expired ES2005549A6 (es) 1986-04-04 1987-04-03 Metodo para preparar una formulacion farmaceutica de liberacion controlada y accion prolongada y metodo de preparar una pluralidad de dosis de dicha formulacion.

Country Status (14)

Country Link
US (1) US4775535A (es)
EP (1) EP0240351B1 (es)
JP (1) JPH0751519B2 (es)
AT (1) ATE77740T1 (es)
AU (1) AU591258B2 (es)
CA (1) CA1297409C (es)
DE (1) DE3780056T2 (es)
ES (1) ES2005549A6 (es)
GR (1) GR3005851T3 (es)
IL (1) IL82092A (es)
MX (1) MX5864A (es)
PL (1) PL264984A1 (es)
YU (1) YU46312B (es)
ZA (1) ZA871818B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
SE9301220D0 (sv) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab Manufacturing matrices
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
CA2354057C (en) 1998-12-11 2009-02-10 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US7130822B1 (en) * 2000-07-31 2006-10-31 Cognos Incorporated Budget planning
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
JP2009514884A (ja) * 2005-11-04 2009-04-09 イーストマン ケミカル カンパニー 難溶性医薬活性剤の投与のためのカルボキシアルキルセルロースエステル
KR100591142B1 (ko) * 2005-11-04 2006-06-20 지엘팜텍 주식회사 파록세틴을 활성물질로 함유하는 장용성 서방형 정제
CN107569690A (zh) * 2012-01-04 2018-01-12 韦尔斯利医药有限公司 用于缓解尿频的延长释放制剂及其使用方法
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US3852421A (en) * 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
US3957525A (en) * 1971-04-24 1976-05-18 Dunlop Limited Road surfacing materials
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
CA945899A (en) * 1971-09-16 1974-04-23 Hans Lowey Long-acting oral carrier
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
GB1430684A (en) * 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
AU591258B2 (en) 1989-11-30
EP0240351A3 (en) 1988-03-02
MX5864A (es) 1994-01-31
EP0240351A2 (en) 1987-10-07
DE3780056T2 (de) 1992-12-24
IL82092A (en) 1990-09-17
IL82092A0 (en) 1987-10-30
YU56987A (en) 1988-08-31
US4775535A (en) 1988-10-04
ATE77740T1 (de) 1992-07-15
EP0240351B1 (en) 1992-07-01
JPH0751519B2 (ja) 1995-06-05
DE3780056D1 (de) 1992-08-06
JPS62294626A (ja) 1987-12-22
CA1297409C (en) 1992-03-17
ZA871818B (en) 1987-09-02
GR3005851T3 (es) 1993-06-07
YU46312B (sh) 1993-05-28
PL264984A1 (en) 1989-03-20
AU7099887A (en) 1987-10-08

Similar Documents

Publication Publication Date Title
ES2005549A6 (es) Metodo para preparar una formulacion farmaceutica de liberacion controlada y accion prolongada y metodo de preparar una pluralidad de dosis de dicha formulacion.
ES2001993A6 (es) Un procedimiento para preparar un agente farmaceutico de liberacion lenta.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
GB2017113A (en) Process for preparing a composition of a polymer and a physiologically active substance
ATE131727T1 (de) Verfahren zur arzneiformulierung sowie arzneimittel
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
ES8506446A1 (es) Procedimiento para preparar formas galenicas que contienen sulfonilureas y-0 derivados del acido benzoico.
ES8502333A1 (es) Un procedimiento para la preparacion de una tableta farmaceutica
DK365488D0 (da) Nye bensimidazolderivater, fremgangsmaade til fremstilling deraf og et farmaceutisk praeparat indeholdende dem
PT76919A (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
NZ236631A (en) Process for the preparation of a spray dried powdered pharmaceutical formulation of naproxen
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
HU173879B (hu) Sposob poluchenija proizvodnykh tetrazolil- i tetrazolilalkil-imidazola i benzimidazola i farmacepticheskikh preparatov, soderzhahhikh ehti soedinenija v kachestve aktivnykh vehhestv
HUT34020A (en) Process for preparing new cyano-guanidine derivatives and pharmaceutical compositions containing such derivatives as active substances
IL59842A0 (en) New biologically active substance obtained from cells of a new microorganism,a process for the preparation thereof and pharmaceutical compositions containing the same
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
HU175305B (hu) Sposob poluchenija nyvykh proizvodnykh biciklogeptena i farmacevticheskikh preparatov soderzhashchikh takie veshchestva kak aktivnye materialy

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102